Skip to main content
. 2020 Jan 8;2020:5354825. doi: 10.1155/2020/5354825

Table 2.

Univariate and multivariate Cox analysis of CD276 expression.

Univariate analysis Multivariate analysis
Variables Hazard ratio 95% CI P Hazard ratio 95% CI P
OS
 Gender (male) 0.82 0.39-1.73 0.601
 Age (≥65) 1.37 0.52-3.57 0.522
 Hormone secretion (yes) 0.76 0.37-1.55 0.445
 Laterality (right) 0.91 0.45-1.86 0.796
 Tumor size (≥7.5) 0.76 0.38-1.52 0.431
 T stage (T3+T4) 1.14 0.52-2.48 0.741
 N stage (N1) 0.76 0.27-2.16 0.605
 Stage (III+IV) 1.06 0.5-2.25 0.88
 R status (R1/2/X) 1.22 0.6-2.47 0.589
 Ki67 index (high) 3.17 1.53-6.56 0.002 3.16 1.52-6.61 0.002
 CD276 tumor cells (high) 2.83 1.29-6.17 0.009 2.8 1.28-6.15 0.01
 CD276 membrane (high) 1.4 0.54-3.66 0.488
 CD276 vascular (positive) 1.26 0.63-2.53 0.517
DFS
 Gender (male) 0.64 0.26-1.54 0.317
 Age (≥65) 0.55 0.13-2.36 0.424
 Hormone secretion (yes) 1.07 0.47-2.41 0.873
 Laterality (right) 1.6 0.71-3.6 0.253
 Tumor size (≥7.5) 0.8 0.36-1.81 0.596
 T stage (T3+T4) 1.62 0.69-3.81 0.272
 N stage (N1) 0.43 0.1-1.83 0.252
 Stage (III+IV) 1.2 0.51-2.83 0.678
 R status (R1/2/X) 3.27 1.44-7.39 0.005 2.8 1.23-6.39 0.014
 Ki67 index (high) 0.85 0.35-2.06 0.72
 CD276 tumor cells (high) 8.13 2.71-24.4 <0.001 7.52 2.47-22.91 <0.001
 CD276 membrane (high) 0.84 0.31-2.28 0.736
 CD276 vascular (positive) 1.15 0.52-2.56 0.733